Fallout season 2 has come to a close, and here are all the video game Easter eggs we spotted ...

Ex Machina, Spider-Man: Into the Spider-Verse, Upgrade, and more make up our list of the best sci-fi movies on Netflix in ...

A report of a Batman movie release date had reignited excitement around DC’s next Dark Knight film, but James Gunn is urging fans not to believe everything they read online just yet. James Gunn says ...

Sci-fi movies are everywhere these days, and the streaming era has made it easier than ever to unearth many of the genre's latest and greatest offerings. Sure, there are plenty of older sci-fi movies ...

Add Yahoo as a preferred source to see more of our stories on Google. According to insider Daniel Richtman, Josh Brolin’s Thanos will reportedly return in Avengers: Secret Wars. However, it’s unclear ...

The Bank of England was advised to create a plan for the inevitable financial chaos that will result if and when world governments disclose the existence of aliens, according to a report. Former ...

FilmLA report found that Hollywood movie and TV productions saw a down year in 2025, but saw a slight bump in the final part of the year. Zach Boetto reports. Trump pardons Puerto Rico's former ...

A new update on the status of DC’s Batman: Brave and the Bold movie suggests that the first entry of DC Universe’s Batman has found a release date window. What is Batman: Brave and the Bold’s ...

The Abyss, The Vast of Night, and David Lynch's Dune are all among the most underrated science fiction movies of the last 100 ...

Chelsea Hylton is a web producer for CBS Los Angeles. An Inglewood native, Hylton has her master's degree from USC. She covers local breaking news across the Southern California region. Before joining ...

If earth just isn’t cutting it anymore and you’re hoping for something a little extraordinary this year, well, this might be good news for you. A recent study has ranked each U.S. state based on which ...

Just days after AbbVie unveiled a major new oncology play in the form of its high-dollar RemeGen collab, the Illinois drugmaker closed out the week with some mixed news for its marketed cancer ...